PHYLLIS GUNDERSEN: Open Payments
NPI 1295785608 · HASTINGS, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$344 in 17 payments from 12 companies in 2025. Trend: 2023 $102 · 2024 $265 · 2025 $344
Food & beverage: $344
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $93 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| Axsome Therapeutics, Inc. | 2 | $34 |
| Novo Nordisk Inc | 1 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $22 |
| Corium, LLC | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Lilly USA, LLC | 1 | $16 |
Products named: VRAYLAR, Auvelity, Wegovy, QULIPTA, CAPLYTA, Azstarys, GEMTESA, AUSTEDO XR.
Industry payments across NE — which companies pay providers there.
